What is cancer screening?
Cancer screening means testing people who feel completely healthy and have no symptoms, to find cancer — or the changes that lead to cancer — at the earliest possible stage. It is fundamentally different from a diagnostic test, which is done after a symptom or lump appears.
The whole idea rests on one simple biological fact: a cancer caught while it is small and confined to its organ of origin is very often curable with straightforward treatment, whereas the same cancer found after it has spread is much harder to cure. Screening tries to shift the moment of diagnosis backwards in time — from "late and symptomatic" to "early and silent."
Screening
Testing a healthy, symptom-free person to detect early cancer or pre-cancer. Example: a mammogram in a woman with no lump.
Diagnosis
Testing a person who already has a symptom (a lump, bleeding, pain) to find its cause. Example: a biopsy of a breast lump.
Early Detection
The umbrella goal — combining public awareness of warning signs with organised screening to find cancer sooner.
Why is screening done — and how does it help?
Screening delivers benefit in four distinct ways. Together these explain why organised screening has driven down deaths from several major cancers across the world.
- Down-staging — finding cancer at an earlier stage. A Stage I breast or colon cancer has a 5-year survival above 90%; the same cancer at Stage IV may fall below 30%. Screening moves diagnoses toward the curable end.
- Preventing cancer altogether. Some screening tests find pre-cancerous changes — a cervical HPV lesion, a colon polyp, an oral white patch — which can be removed before they ever become cancer. This is true prevention, not just early detection.
- Less aggressive treatment. Early cancers often need smaller operations, and less (or no) chemotherapy and radiation — meaning fewer side-effects, lower cost and better quality of life.
- Higher cure rates and lower mortality. Randomised trials show screening reduces death from breast, cervical and colorectal cancer by roughly 20–50% in screened populations.
The single most important number in cancer is the stage
Across almost every solid cancer, survival falls sharply as the stage rises. This is the entire rationale for screening — captured in one pattern:
Illustrative survival ranges vary by cancer type; the consistent lesson is that earlier stage means dramatically better outcomes.
Why is screening done for only a few cancers — not all?
It is a common and reasonable question: if screening finds cancer early, why not screen for every cancer? The answer is that screening only helps when a specific set of conditions is met. In 1968, Wilson and Jungner defined the classic criteria that a screening programme must satisfy — still used worldwide today. A cancer is only worth screening for when all of these hold true:
The cancer is a common and important health problem.
Its natural history is understood — there is a recognisable early or pre-cancerous stage.
A suitable test exists that is accurate, safe and acceptable to healthy people.
The test is affordable and can be offered at scale.
An effective treatment exists for the early disease that is found.
Treating early actually improves survival compared with treating later.
When even one criterion fails, screening can do more harm than good. This is why, for many cancers, no screening test is recommended for the general population — not because doctors have neglected them, but because the evidence shows screening would not save lives, and could cause real harm.
Screening also has real harms — which is why it must be targeted
An honest account of screening includes its downsides. These harms are exactly why screening is offered only where trials prove the benefit outweighs them:
False positives
An abnormal result in someone who does not have cancer — causing anxiety, extra scans and sometimes needless biopsies.
Over-diagnosis
Finding a slow, harmless cancer that would never have caused problems in a person's lifetime — leading to treatment that only causes harm.
False reassurance
A normal result can occasionally miss a real cancer (a false negative), delaying diagnosis if new symptoms are ignored.
Cost & anxiety
Whole-body "cancer packages" marketed to the healthy often generate incidental findings, cost and worry without evidence of saving lives.
Cancers where screening is proven to save lives
For these cancers, high-quality evidence — including randomised trials — shows that organised screening finds disease earlier and reduces deaths. These are the tests worth having.
Breast Cancer
Mammography · Clinical Breast Exam · Self-Awareness
- Mammography every 1–2 years, typically from age 40–45 (earlier if high risk or family history).
- Clinical breast examination and breast self-awareness for all women.
- In India, clinical breast exam every 2–3 years achieves valuable down-staging where mammography isn't available.
Cervical Cancer
HPV Test · Pap Smear · VIA
- HPV testing every 5 years (preferred) or Pap smear every 3 years, ages 25/30–65.
- Finds pre-cancer (CIN) that can be treated before cancer ever develops — true prevention.
- HPV vaccination in girls dramatically reduces future cervical cancer.
Short▶
Colorectal Cancer
Colonoscopy · FIT Stool Test
- Colonoscopy every 10 years, or a faecal immunochemical test (FIT) yearly, from age 45–50.
- Removing polyps at colonoscopy prevents cancer from forming at all.
- Now recommended earlier as colorectal cancer rises in younger adults.
Oral Cancer
Visual Oral Examination
- Simple visual and manual examination of the mouth — especially vital in India, where oral cancer is among the commonest cancers.
- Targeted at tobacco and areca-nut users, in whom it is proven to reduce mortality.
- Detects pre-cancerous patches (leukoplakia, erythroplakia) that can be treated early.
Lung Cancer
Low-Dose CT (LDCT)
- Yearly low-dose CT for heavy smokers / ex-smokers, roughly ages 50–80 with a significant smoking history.
- Proven to reduce lung cancer deaths in this high-risk group (NLST, NELSON trials).
- Not for people who have never smoked — the benefit does not apply.
Selective / High-Risk
For specific risk groups only
- Prostate (PSA): after individual discussion of risks and benefits, typically age 50+.
- Liver: ultrasound for people with cirrhosis or chronic hepatitis B/C.
- Stomach: endoscopic screening in high-incidence regions / high-risk individuals.
- Hereditary syndromes: tailored programmes for BRCA, Lynch and familial cancers.
Cancers where routine screening is not recommended
For many cancers there is currently no test that reliably saves lives when used on the general, symptom-free population. This may be because the cancer is uncommon, grows unpredictably, has no reliable early test, or because trials have shown screening does not reduce deaths. For these, the right approach is awareness of symptoms and prompt evaluation — not routine screening.
Ovarian cancer
Blood tests (CA-125) and ultrasound have not reduced deaths in trials and cause many false alarms.
Pancreatic cancer
No effective population test; screened only in specific high-risk hereditary groups.
Kidney & bladder
No proven general screening test; investigated promptly when symptoms (e.g. blood in urine) appear.
Brain & blood cancers
No screening test; diagnosed on the basis of symptoms and clinical evaluation.
Thyroid cancer
Population screening finds many harmless cancers (over-diagnosis) without saving lives — so it is not recommended for the healthy.
Most rare cancers
Too uncommon for screening to be efficient; managed through symptom awareness and specialist referral.
Better than screening — preventing cancer in the first place
A large share of cancers are preventable. Screening finds cancer early; prevention stops it from ever starting. Both matter — but prevention is the most powerful tool of all.
Avoid tobacco & areca nut
Tobacco (smoked and chewed) and areca/gutka are the single biggest cause of cancer in India — mouth, lung, throat, food-pipe and more. Quitting at any age reduces risk.
Vaccination
HPV vaccine prevents cervical and other HPV-related cancers; Hepatitis B vaccine prevents liver cancer.
Healthy weight & diet
A diet rich in fruit, vegetables and fibre, limiting red/processed meat, and keeping a healthy weight lowers risk of several cancers.
Physical activity
Regular exercise reduces the risk of breast, colon and other cancers, and aids recovery.
Limit alcohol
Alcohol is a proven cause of breast, liver, mouth and food-pipe cancers — less is better.
Sun & infection safety
Sun protection lowers skin cancer risk; treating chronic infections (H. pylori, hepatitis) lowers stomach and liver cancer risk.
Warning signs you should never ignore
Screening is for the healthy; these warning signs are for everyone. Any of the following, if persistent, deserves prompt medical evaluation — early action can be life-saving.
What the literature shows
The recommendations on this page reflect the major international and Indian guidelines and the landmark trials behind them. Screening policy is built on decades of randomised evidence — not opinion.
Breast — down-staging & mortality
Randomised trials of mammography show reduced breast-cancer mortality; Indian CBE trials (Mumbai, TMH) show screening every 2–3 years achieves down-staging and survival benefit.
Cervical — VIA & HPV
Two large Indian RCTs showed VIA (visual inspection with acetic acid) reduced cervical-cancer mortality by over 30%. HPV testing is now the preferred global standard (ACS/WHO).
Colorectal — polypectomy prevents cancer
Colonoscopy and FIT reduce colorectal-cancer incidence and death; removing adenomatous polyps prevents cancer (USPSTF, ACS).
Lung — low-dose CT
The NLST and NELSON trials showed low-dose CT reduces lung-cancer deaths in heavy smokers — but only in that high-risk group (USPSTF).
Oral — targeted visual screening
The Kerala oral screening trial showed a mortality benefit from visual oral screening in tobacco/alcohol users — the basis for targeted oral screening in India.
Frameworks & guidelines
Wilson & Jungner criteria (WHO, 1968); USPSTF and American Cancer Society guidelines; ICMR & National Cancer Grid (India) operational guidelines.
Sources: US Preventive Services Task Force; American Cancer Society (CA: A Cancer Journal for Clinicians); Indian Council of Medical Research (ICMR-NICPR) & National Cancer Grid; NLST and NELSON lung trials; Indian cervical and oral screening RCTs. Guidance here is general and educational — your personal screening plan should be decided with your doctor.
When should you be screened?
Screening is not one-size-fits-all — the right tests and timing depend on your age, sex, family history and risk factors such as tobacco use. As a general starting point:
| Cancer | Who / When | Test |
|---|---|---|
| Breast | Women, from age 40–45 (earlier if family history) | Mammography ± clinical breast exam |
| Cervical | Women, age 25/30–65 | HPV test every 5 yrs / Pap every 3 yrs |
| Colorectal | All, from age 45–50 | Colonoscopy (10 yrs) or FIT (yearly) |
| Oral | Tobacco / areca-nut users | Visual oral examination |
| Lung | Heavy smokers / ex-smokers, ~50–80 | Annual low-dose CT |
| High-risk / hereditary | Family history, genetic syndromes | Individualised plan |
A short consultation can build a personalised screening plan for you and your family — especially valuable if cancer runs in your family.